Commercial Strategy for Healthcare Innovation
We help healthcare innovators make the commercial decisions that determine value long before commercialization begins.
From early development through market creation and launch, Alpenglow works with C-Suite leaders, boards and investors at the moments when science and technology, market and enterprise strategy have to come together to create value and drive patient impact.
1) See What Others Miss
Twenty-five years of pattern recognition from inside companies that launched, defended and created markets.
2) Challenge the Assumptions
Independent judgment on the assumptions shaping your valuation, development plan and board narrative.
3) Build the Path to Adoption
Decades of market development experience aligning patient access, care delivery and payer coverage for your innovation.
Three Ways to Engage
-
Will the market adopt your science and technology, and what will it take to reach patients, deliver care and secure payment?
Best For: Preclinical through Phase II therapeutics, and medtech and health technology companies building a new market, category or care pathway.
Deliverables: Commercialization Blueprint, Market Blueprint
-
Are we as commercially attractive as we believe we are?
We are about to make an expensive and potentially irreversible decision. What do we need to know before we make it?
Where should we place our next dollar, and which opportunities can create the greatest strategic value?
The market may be large, but will this innovation actually be adopted?
Best For:
C-suite leaders, boards and investors preparing for a major capital, development or strategic decision
Companies approaching Phase 2 data, Phase 3 investment, financing, partnering, acquisition or their first commercial hire
C-suite leaders, boards and investors prioritizing assets, indications or growth opportunities
Venture, private equity and growth investors, boards and strategic partners evaluating a transaction
Deliverables:
Market Reality Brief
Decision Roadmap
Portfolio + Value Roadmap
Commercial Adoption Due Diligence
-
Are we building the conditions required for launch success before we build the launch organization?
Who can be our senior commercial thought partner, connecting science and technology, market realities and enterprise decisions to build the conditions for launch success before we build the launch organization?
Best For: Companies 18 to 36 months from potential commercialization and C-suite teams needing a senior commercial voice before hiring a full-time CCO
Deliverables: Launch Roadmap, Ongoing Counsel for C-Suite Leadership
We're operators. We've built, launched and scaled brands from the inside, so we know what good looks like.
Founder Deanna Angello is a C-level biopharma operator with 25+ years of experience translating breakthrough science into adoption, access, and durable growth across Fortune 50 (Pfizer, Genentech/Roche, Kite Pharma, Johnson & Johnson), clinical-stage innovators and emerging growth companies.
